AT249277B - Verfahren zur Herstellung neuer Benzomorphane - Google Patents

Verfahren zur Herstellung neuer Benzomorphane

Info

Publication number
AT249277B
AT249277B AT392965A AT392965A AT249277B AT 249277 B AT249277 B AT 249277B AT 392965 A AT392965 A AT 392965A AT 392965 A AT392965 A AT 392965A AT 249277 B AT249277 B AT 249277B
Authority
AT
Austria
Prior art keywords
benzomorphans
new
production
new benzomorphans
Prior art date
Application number
AT392965A
Other languages
English (en)
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Application granted granted Critical
Publication of AT249277B publication Critical patent/AT249277B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT392965A 1963-12-20 1964-12-18 Verfahren zur Herstellung neuer Benzomorphane AT249277B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
AT249277B true AT249277B (de) 1966-09-12

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
AT1074364A AT253687B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung von neuen Benzomorphanen
AT392865A AT249276B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung neuer Benzomorphane
AT392965A AT249277B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung neuer Benzomorphane
AT1074264A AT261126B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung von neuen Benzomorphanen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT1074364A AT253687B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung von neuen Benzomorphanen
AT392865A AT249276B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung neuer Benzomorphane

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT1074264A AT261126B (de) 1963-12-20 1964-12-18 Verfahren zur Herstellung von neuen Benzomorphanen

Country Status (12)

Country Link
AT (4) AT253687B (de)
BE (2) BE657406A (de)
CH (7) CH449643A (de)
DE (2) DE1445854A1 (de)
DK (4) DK108495C (de)
ES (4) ES307300A1 (de)
FR (2) FR4345M (de)
GB (2) GB1077711A (de)
IL (2) IL22642A (de)
NL (3) NL6414820A (de)
NO (2) NO119274B (de)
SE (2) SE322779B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
AU2003234621A1 (en) 2002-05-17 2003-12-02 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2125750B1 (de) 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Zyklische harnstoff- und carbamat-hemmer aus 11-beta-hydroxysteroid-dehydrogenase 1
US8329897B2 (en) 2007-07-26 2012-12-11 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
EP2220048B1 (de) 2007-11-16 2017-01-25 Boehringer Ingelheim International GmbH Aryl- und heteroarylcarbonylderivate von benzomorphanen und verwandten grundgerüsten, solche verbindungen enthaltende medikamente und deren verwendung
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (de) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclische carbazate und semicarbazide als inhibitoren von 11beta-hydroxysteroiddehydrogenase 1
CA2714532A1 (en) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
ATE531696T1 (de) * 2008-02-12 2011-11-15 Boehringer Ingelheim Int Harnstoff-derivate von benzomorphanen, entsprechende gerüste, medikamente mit solchen verbindungen und ihre verwendung
EP2254872A2 (de) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyllactamderivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
CA2722427A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (de) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclische inhibitoren von 11beta-hydroxysteroiddehydrogenase 1
WO2009138386A2 (en) 2008-05-13 2009-11-19 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
RU2539979C2 (ru) 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
EP2350068B1 (de) 2008-10-23 2017-08-30 Boehringer Ingelheim International GmbH Harnstoffderivate substituierter nortropane, medikamente, die solche verbindungen enthalten, und ihre verwendung
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
JP5670440B2 (ja) 2009-06-02 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
EP2440537A1 (de) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclische hemmer der 11beta-hydroxysteroiddehydrogenase 1 auf basis der 1,3 -oxazinan- 2 -on-struktur
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TWI531571B (zh) 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
EP2582698B1 (de) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituierte 5-,6- und 7-gliedrige heterocyclen, medikamente mit derartigen verbindungen und ihre verwendung
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
BR112013010021A2 (pt) 2010-11-02 2019-09-24 Boehringer Ingelheim Int combinações farmacêuticas para o tratamento de distúrbios metabólicos.
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体

Also Published As

Publication number Publication date
DK106552C (da) 1967-02-20
ES307301A1 (es) 1965-05-16
ES307299A1 (es) 1965-05-16
NL6414820A (de) 1965-06-21
CH449642A (de) 1968-01-15
ES307300A1 (es) 1965-05-01
AT253687B (de) 1967-04-25
SE322779B (de) 1970-04-20
NO119274B (de) 1970-04-27
CH449639A (de) 1968-01-15
DE1445854A1 (de) 1968-12-05
SE305657B (de) 1968-11-04
CH449640A (de) 1968-01-15
BE657406A (de) 1965-06-21
NO119273B (de) 1970-04-27
CH448118A (de) 1967-12-15
GB1077711A (en) 1967-08-02
DK108496C (da) 1967-12-27
CH449643A (de) 1968-01-15
CH449641A (de) 1968-01-15
DE1445853A1 (de) 1968-12-05
FR4346M (de) 1966-08-16
AT261126B (de) 1968-04-10
IL22642A (en) 1968-07-25
GB1092394A (en) 1967-11-22
NL6414821A (de) 1965-06-21
DK108495C (da) 1967-12-27
NL127995C (de)
AT249276B (de) 1966-09-12
CH446371A (de) 1967-11-15
FR4345M (de) 1966-08-16
IL22643A (en) 1968-07-25
BE657405A (de) 1965-06-21
DK108497C (da) 1967-12-27
ES307302A1 (es) 1965-05-16

Similar Documents

Publication Publication Date Title
AT249276B (de) Verfahren zur Herstellung neuer Benzomorphane
CH443329A (de) Verfahren zur Herstellung von neuen Benzomorphane
CH474486A (de) Verfahren zur Herstellung neuer Diphenylharnstoffe
CH470345A (de) Verfahren zur Herstellung neuer Styryläthanolamine
CH519488A (de) Verfahren zur Herstellung neuer 19-Nor-androstatriene
AT248454B (de) Verfahren zur Herstellung neuer Organomolybdänverbindungen
CH441332A (de) Verfahren zur Herstellung neuer Benzolsulfonylsemicarbazide
AT252210B (de) Verfahren zur Herstellung von Phenolen
CH490350A (de) Verfahren zur Herstellung neuer antidiabetisch wirksamer Benzolsulfonyl-semicarbazide
CH443310A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
AT257934B (de) Verfahren zur Herstellung neuer Alkydharze
CH432538A (de) Verfahren zur Herstellung neuer Yohimban-Derivate
CH435261A (de) Verfahren zur Herstellung neuer 19-Nor-androstene
CH454138A (de) Verfahren zur Herstellung neuer Zinnkomplexsalze
CH468973A (de) Verfahren zur Herstellung neuer Acylamino-phenylarylketone
CH434520A (de) Verfahren zur Herstellung neuer Disazopigmente
CH473807A (de) Verfahren zur Herstellung neuer 4-Hydroxy-chinoline
CH442294A (de) Verfahren zur Herstellung neuer 7a-Methyl-androstene
AT252260B (de) Verfahren zur Herstellung neuer Kondensationsprodukte
AT248694B (de) Verfahren zur Herstellung neuer Telomerisate
CH475943A (de) Verfahren zur Herstellung neuer B-Alkoxy-trifluormethyl-phenäthyl-tert.-amine
CH439307A (de) Verfahren zur Herstellung neuer Phthalazinium-Verbindungen
CH481083A (de) Verfahren zur Herstellung neuer 4-Halogen-androstene
CH455757A (de) Verfahren zur Herstellung neuer Phenyl-cyclohexylalkylamine
CH443286A (de) Verfahren zur Herstellung neuer 7-a-Methyl-androstene